Recombinant human erythropoietin trial in thalassemia intermedia

Journal of Tropical Pediatrics

Volumn 42, Issue 6, 1996, Pages 330-334

  Nişli, Güngör ^a   Kavakli, Kaan ^a   Vergin, Canan ^a   Öztop, Senay ^a   Çetingül, Nazan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERRITIN; HEMOGLOBIN; HEMOGLOBIN F; RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; ALOPECIA; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HUMAN; INJECTION PAIN; MALE; MYALGIA; PRURITUS; QUALITY OF LIFE; RETICULOCYTE COUNT; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA INTERMEDIA;

EID: 0030450965     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/42.6.330     Document Type: Article

References (18)

1. Blau AC, Stamatoyannopoulos G. Evolving therapies in globin gene disorders. In: Lechner K, Gadner H, eds. Hematology trends '93. Stuttgart: Schattauer Co, 1993; 144-58.
2. Stamatoyannopoulos G, Veith R, Al-Khatti A, Papayannopouou T. Induction of fetal hemoglobin by cell-cycle-specific drugs and recombinant erythropoietin. Am J Pediat Hematol Oncol 1990; 12: 21-6.
3. Winearls CG, Oliver DO, Pippard MJ, Reid C. Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic haemodialysis. Lancet 1986; 22: 1175-1178.
4. Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989; 73: 100-3.
5. De Simone, Holler P, Hall L, Swiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Nat Acad Sci 1982; 79: 4428-31.
6. + Thalassemia. N Engl J Med 1982; 307: 1469-75.
7. Rachmilewitz EA, Goldfarb A, Dover G Administration of erythropoietin to patients with beta-Thalassemia: a preliminary trial. Blood 1991; 78: 1145-7.
8. Olivieri NF, Freedman MH, Perrine SP, Dover GJ. Trial of recombinant human erythropoietin: three patients with thalassemia intermedia. Blood 1992; 80: 3258-60.
9. Pembrey ME, McWade P, Weatherall DJ. Reliable routine estimation of small amounts of fetal haemoglobin by alkali denaturation. J Clin Pathol 1982; 77: 568.
10. Kleihauer E, Hildegard B, Betke K. Demontration von fetalen haemaglogin in den erythrocyten eines blutausstrichs. Klin Wachenschr 1957; 35: 637.
11. Andre M, Forster A, Toppet M, Fondu P, Dratwa M, Bergman P. Performance of an immunoradiometric assay of erythropoietin and results for specimens from anemic and polycythemic patients. Clin Chem 1992; 38: 758-63.
12. Leroy-Viard K, Rouver-Fessard P, Beuzard Y. Improved mouse beta-thalassemia by recombinant human erythropoietin. Blood 1991; 78: 1596-602.
13. Galanello R, Stamatoyannopoulos G, Papayannopoulo T. Mechanism of Hb F production in stressed erythropoiesis: observations and kinetic models. Ann NY Acad Sci 1985; 445: 188-97.
14. Rodgers GP, Dover GJ, Uyeseka N, Noguchi CT. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med 1993; 328: 73-80.
15. Fibach E, Schechter AN, Noguchi CT, Rodgers GP. Reducing erythropoietin in cultures of human erythroid precursors elevates the proportion of fetal haemoglobin. Br J Haematol 1994; 88: 39-45.
16. DeSimone J, Biel M, Heller P. Maintenance of fetal hemoglobin elevations in the baboons by prolonged erythropoietic stress. Blood 1991; 78: 1145-7.
17. Sikole A, Efromov DG, Dimovski A, et al. Hemoglobin F levels in end-stage renal disease patients after correction of anemia with erythropoietin. Nephron 1993; 65: 456-9.
18. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990; 248: 378-81.